The Cross-Border Biotech Blog

Biotechnology, Health and Business in Canada, the United States and Worldwide

Essex Woodland Health Ventures’ New $900 million Bio Fund

Essex Woodlands Health Ventures closed on its Fund VIII today with $900 million to invest “across the spectrum of drug, device and service companies in North America, Europe and Asia.”  The In Vivo blog points out that this isn’t exactly new news, but it is still good news for companies that are now a big step closer to seeing the money deployed.

One Canadian connection I was able to turn up: Dr. C. Thomas Caskey is an Adjunct Partner to Essex Woodlands and also sits on the Genome Canada Board.

Bookmark and Share

About these ads

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

Follow

Get every new post delivered to your Inbox.

Join 129 other followers